ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Portfolio Tracker
Get an update on your stocks every day. See earnings revisions, new reports and Zacks Rank changes at a glance. Click here to learn more.

Quote:

Search for Ticker

Free Membership

Search:

TECH: Techne Cp - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

TECHNE CP (NASD)
TECH	67.47	0.35	(0.52%)	Vol. 20,243	11:12 ET

Techne Corporation is a holding company which has two wholly-owned operating subsidiaries: Research and Diagnostic Systems, Inc. and R&D Systems Europe Ltd. Research and Diagnostic Systems, Inc. is a specialty manufacturer of biological products. R&D Europe distributes Research and Diagnostic Systems' biotechnology products in Europe. Its two major operating segments are hematology controls, which are used in hospital and clinical laboratories to check the accuracy of blood analysis instruments, and biotechnology products including purified proteins and antibodies.

General Information

TECHNE CORP

614 McKinley Place NE Minneapolis, MN 55413 Phone: 612 379-8854 Fax: 612 379-6580 Web: www.techne-corp.com Email: techinfo@techne-corp.com

Industry	MED INSTRUMENTS
Sector:	Medical

Fiscal Year End	June
Last Reported Quarter	09/30/09
Next EPS Date	02/09/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	67.12
52 Week High	68.23
52 Week Low	45.38
Beta	0.69
20 Day Moving Average	129,659.60
Target Price Consensus	68

% Price Change
4 Week	5.58
12 Week	8.63
YTD	4.03

% Price Change Relative to S&P 500
4 Week	4.44
12 Week	2.41
YTD	-13.90

Share Information
Shares Outstanding (millions)	37.24
Market Capitalization (millions)	2,499.89
Short Ratio	5.06
Last Split Date	12/04/2000

Dividend Information
Dividend Yield	1.55%
Annual Dividend	$1.04
Payout Ratio	0.36
Change in Payout Ratio	0.29
Last Dividend Payout / Amount	11/05/2009 / $0.26

EPS Information
Current Quarter EPS Consensus Estimate	0.68
Current Year EPS Consensus Estimate	2.97
Estimated Long-Term EPS Growth Rate	11.00
Next EPS Report Date	02/09/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	1.50
30 Days Ago	1.50
60 Days Ago	1.50
90 Days Ago	1.50

Fundamental Ratios

P/E
Current FY Estimate:	22.58
Trailing 12 Months:	24.32
PEG Ratio	2.05

EPS Growth
vs. Previous Year	-2.70%
vs. Previous Quarter	5.88%

Sales Growth
vs. Previous Year	-4.02%
vs. Previous Quarter:	2.53%

Price Ratios
Price/Book	5.31
Price/Cash Flow	22.12
Price / Sales	9.57

ROE
09/30/09	23.31
06/30/09	23.49
03/31/09	23.50

ROA
09/30/09	22.55
06/30/09	22.69
03/31/09	22.67

Current Ratio
09/30/09	17.57
06/30/09	16.46
03/31/09	14.93

Quick Ratio
09/30/09	16.80
06/30/09	15.73
03/31/09	14.21

Operating Margin
09/30/09	39.60
06/30/09	39.87
03/31/09	40.14

Net Margin
09/30/09	58.25
06/30/09	58.86
03/31/09	59.38

Pre-Tax Margin
09/30/09	58.25
06/30/09	58.86
03/31/09	59.38

Book Value
09/30/09	12.65
06/30/09	12.26
03/31/09	11.39

Inventory Turnover
09/30/09	4.99
06/30/09	5.34
03/31/09	5.50

Debt-to-Equity
09/30/09	0.00
06/30/09	0.00
03/31/09	0.00

Debt to Capital
09/30/09	0.00
06/30/09	0.00
03/31/09	0.00


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research